188 related articles for article (PubMed ID: 36013322)
1. Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer.
Kumar DN; Chaudhuri A; Dehari D; Shekher A; Gupta SC; Majumdar S; Krishnamurthy S; Singh S; Kumar D; Agrawal AK
Life (Basel); 2022 Jul; 12(8):. PubMed ID: 36013322
[TBL] [Abstract][Full Text] [Related]
2. Milk-derived exosomes for oral delivery of paclitaxel.
Agrawal AK; Aqil F; Jeyabalan J; Spencer WA; Beck J; Gachuki BW; Alhakeem SS; Oben K; Munagala R; Bondada S; Gupta RC
Nanomedicine; 2017 Jul; 13(5):1627-1636. PubMed ID: 28300659
[TBL] [Abstract][Full Text] [Related]
3. Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes.
Kandimalla R; Aqil F; Alhakeem SS; Jeyabalan J; Tyagi N; Agrawal A; Yan J; Spencer W; Bondada S; Gupta RC
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359601
[TBL] [Abstract][Full Text] [Related]
4. Impact of the Drug Loading Method on the Drug Distribution and Biological Efficacy of Exosomes.
Kumar DN; Chaudhuri A; Kumar D; Singh S; Agrawal AK
AAPS PharmSciTech; 2023 Aug; 24(6):166. PubMed ID: 37552397
[TBL] [Abstract][Full Text] [Related]
5. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
6. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of paclitaxel-loaded and folic acid-modified poly (lactic-co-glycolic acid) nano-micelles and in vitro anticancer effect on cervical cancer HeLa cells].
Li XJ; You Y; Zhang QL; Zhang BB; Yan L; Ou ZM; Zhang Y; Wang YJ; Tong Y; Liu DW; Wang JY
Zhongguo Zhong Yao Za Zhi; 2021 May; 46(10):2481-2488. PubMed ID: 34047094
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.
Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J
J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917
[TBL] [Abstract][Full Text] [Related]
10. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
[TBL] [Abstract][Full Text] [Related]
11. Combination Therapy with Resveratrol and Celastrol Using Folic Acid-Functionalized Exosomes Enhances the Therapeutic Efficacy of Sepsis.
Zheng X; Xing Y; Sun K; Jin H; Zhao W; Yu F
Adv Healthc Mater; 2023 Nov; 12(29):e2301325. PubMed ID: 37530416
[TBL] [Abstract][Full Text] [Related]
12. Folic Acid-Functionalized Gold Nanorods for Controlled Paclitaxel Delivery: In Vitro Evaluation and Cell Studies.
Papaioannou L; Angelopoulou A; Hatziantoniou S; Papadimitriou M; Apostolou P; Papasotiriou I; Avgoustakis K
AAPS PharmSciTech; 2018 Dec; 20(1):13. PubMed ID: 30560417
[TBL] [Abstract][Full Text] [Related]
13. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles.
Zhao D; Zhao X; Zu Y; Li J; Zhang Y; Jiang R; Zhang Z
Int J Nanomedicine; 2010 Sep; 5():669-77. PubMed ID: 20957218
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
16. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
Klaassen U; Wilke H; Seeber S
J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
[TBL] [Abstract][Full Text] [Related]
17. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.
Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM
Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480
[TBL] [Abstract][Full Text] [Related]
18. Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment.
Raikwar S; Vyas S; Sharma R; Mody N; Dubey S; Vyas SP
AAPS PharmSciTech; 2018 Nov; 19(8):3839-3849. PubMed ID: 30280350
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer.
Erdoğar N; Esendağlı G; Nielsen TT; Esendağlı-Yılmaz G; Yöyen-Ermiş D; Erdoğdu B; Sargon MF; Eroğlu H; Bilensoy E
J Drug Target; 2018 Jan; 26(1):66-74. PubMed ID: 28581827
[TBL] [Abstract][Full Text] [Related]
20. Exosomal delivery of berry anthocyanidins for the management of ovarian cancer.
Aqil F; Jeyabalan J; Agrawal AK; Kyakulaga AH; Munagala R; Parker L; Gupta RC
Food Funct; 2017 Nov; 8(11):4100-4107. PubMed ID: 28991298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]